Dave Stack is currently the Chief Executive Officer and Chairman of Pacira Pharmaceuticals, Inc. He is also a Managing Director at MPM Capital. From September 2001 until August 2004, Mr. Stack was President, CEO and Director of The Medicines Company (NASDAQ: MDCO). Prior to The Medicines Company, he was the CEO of Stack Pharmaceuticals, Inc., where The Medicines Company was one of its primary customers. From May 1995 to December 1999, he served as the President and General Manager of Innovex, Inc., responsible for the Americas. Innovex, Inc. was a commercial solutions company offering a full range of marketing, sales and clinical development capabilities to pharmaceutical and biotechnology customers, and was sold to Quintiles in November 1997 for $897 million. From April 1993 to May 1995, he was the Vice President of Business Development and Marketing for Immunomedics, Inc. (NASDAQ: IMMU), a biopharmaceutical company focusing on monoclonal antibodies in infectious disease and oncology. From May 1992 to March 1993, Mr. Stack was the Director of Business Development and Planning for Infectious Disease, Oncology and Virology for Roche Labs where he was the Therapeutic World Leader for Infectious Disease. Prior to that role, he held various positions with Roche Labs for approximately 12 years and was a retail and hospital pharmacist for three years after graduating from Albany College of Pharmacy. He also holds a Bachelor of Science in Biology from Siena College, where he is currently a Trustee. Mr. Stack was recognized as the Ernst and Young Entrepreneur of the Year in 2003 (New Jersey Healthcare). He is a Director of Amarin Corporation plc and Medivo Inc, serves as Chairman of Chiasma, Inc. and is on the Board of Directors of the Biotechnology Industry Organization’s (BIO) Emerging Company and Health Sections. Dave Stack is currently the Chief Executive Officer and Chairman of Pacira Pharmaceuticals, Inc. He is also a Managing Director at MPM Capital. From September 2001 until August 2004, Mr. Stack was President, CEO and Director of The Medicines Company (NASDAQ: MDCO). Prior to The Medicines Company, he was the CEO of Stack Pharmaceuticals, Inc., where The Medicines Company was one of its primary customers. From May 1995 to December 1999, he served as the President and General Manager of Innovex, Inc., responsible for the Americas. Innovex, Inc. was a commercial solutions company offering a full range of marketing, sales and clinical development capabilities to pharmaceutical and biotechnology customers, and was sold to Quintiles in November 1997 for $897 million. From April 1993 to May 1995, he was the Vice President of Business Development and Marketing for Immunomedics, Inc. (NASDAQ: IMMU), a biopharmaceutical company focusing on monoclonal antibodies in infectious disease and oncology. From May 1992 to March 1993, Mr. Stack was the Director of Business Development and Planning for Infectious Disease, Oncology and Virology for Roche Labs where he was the Therapeutic World Leader for Infectious Disease. Prior to that role, he held various positions with Roche Labs for approximately 12 years and was a retail and hospital pharmacist for three years after graduating from Albany College of Pharmacy. He also holds a Bachelor of Science in Biology from Siena College, where he is currently a Trustee. Mr. Stack was recognized as the Ernst and Young Entrepreneur of the Year in 2003 (New Jersey Healthcare). He is a Director of Amarin Corporation plc and Medivo Inc, serves as Chairman of Chiasma, Inc. and is on the Board of Directors of the Biotechnology Industry Organization’s (BIO) Emerging Company and Health Sections.

Oncology